
Full profile: /officials/P000605
Source: Congress.gov · FEC
Members who have signed on to support this bill since introduction. Source: Congress.gov.
No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Currently in
The Department of Veterans Affairs would be required to offer stellate ganglion block procedures—injections that numb nerve clusters in the neck to reduce pain and stress responses—to veterans diagnosed with post-traumatic stress disorder. This treatment option would give veterans with PTSD access to a medical procedure that some research suggests may help reduce PTSD symptoms, alongside or instead of traditional treatments like therapy and medication. The change would expand the VA's treatment options for the roughly 3.6 million veterans living with PTSD.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 8763 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 8763 To direct the Secretary of Veterans Affairs to furnish stellate ganglion block to veterans with post-traumatic stress disorder, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES May 12, 2026 Mr. Perry introduced the following bill; which was referred to the Committee on Veterans' Affairs _______________________________________________________________________ A BILL To direct the Secretary of Veterans Affairs to furnish stellate ganglion block to veterans with post-traumatic stress disorder, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Treatment and Relief through Emerging and Accessible Therapy for PTSD VA Act'' or the ``TREAT PTSD VA Act''. SEC. 2. PROVISION OF STELLATE GANGLION BLOCK TO VETERANS WITH POST- TRAUMATIC STRESS DISORDER. (a) Provision to Veterans.-- (1) In general.--Subchapter II of chapter 17 of title 38, United States Code, is amended by adding at the end the following new section: ``Sec. 1720M. Provision of stellate ganglion block for certain veterans ``(a) In General.--The Secretary shall furnish stellate ganglion block to any veteran who-- ``(1) is enrolled in the patient enrollment system under section 1705 of this title; ``(2) has been diagnosed with post-traumatic stress disorder; and ``(3) has elected to receive stellate ganglion block after being informed by a qualified health care provider of the risks and benefits of stellate ganglion block. ``(b) Provision of Care.--The Secretary may furnish stellate ganglion block under subsection (a) through a medical facility of the Department or through a health care provider specified in section 1703(c) of this title.''. (2) Clerical amendment.--The table of contents at the beginning of chapter 17 of title 38, United States Code, is amended by inserting after the item relating to section 1720L the following new item: ``1720M. Provision of stellate ganglion block for certain veterans.''. (b) Update of Joint Clinical Practice Guideline.-- (1) Update of guideline.--Not later than 180 days after the date of the enactment of this Act, the Secretary of Veterans Affairs shall update the guideline titled the ``VA/DOD Clinical Practice Guideline (CPG) for the Management of PTSD'' (or such successor guideline) to ensure the guideline-- (A) reflects the availability of stellate ganglion block as a therapy option; and (B) includes information on the clinical indicators and contraindicators for such therapy option. (2) Notification.--Upon updating the guideline under paragraph (1), the Secretary shall notify the Committees on Veterans' Affairs of the House of Representatives and the Senate of such update. (c) Effective Date.--The amendment made by subsection (a) shall take effect on the date that is 180 days after the date of the enactment of this Act. <all>
Bills by the same sponsor or covering overlapping subjects.